Drug Administration Device Synchronizing Release to Circadian Rhythms

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medical devices for hypertension treatment do not account for the circadian rhythms of patients, leading to inefficiencies in drug administration and potential side effects due to non-timed drug releases.

Innovation Solution

A device that measures and normalizes body parameters over cycles, allowing for personalized drug administration based on individual circadian patterns, using a measuring means to track body parameters like blood pressure and adjusting drug release accordingly.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If drug administration is performed at fixed intervals regardless of patient's circadian rhythm, then device complexity is reduced and ease of operation is improved, but treatment effectiveness decreases and side effects increase

Engineering Contradiction:
Improveease of drug administrationVSAvoidtreatment effectiveness
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent implements dynamic drug administration timing that adapts to the patient's individual circadian rhythm. The system continuously monitors body temperature to detect circadian patterns and automatically adjusts drug release timing and dosage, transforming fixed-interval administration into a dynamic, rhythm-synchronized process that maintains treatment effectiveness while simplifying patient operation.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system employs feedback mechanisms where body temperature measurements are continuously taken, circadian rhythms are analyzed from this data, and drug administration parameters are adjusted based on the detected rhythm. This closed-loop feedback ensures treatment effectiveness is maintained while the system adapts to individual patient patterns over time.

Inventive Principle:
Principle #23Feedback

2Measurement precision

If continuous monitoring of multiple body parameters is performed, then measurement precision and reliability of patient status control are improved, but device complexity and energy consumption increase

Engineering Contradiction:
Improvepatient status monitoring accuracyVSAvoidmeasurement system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts and utilizes only the most informative body parameter for circadian rhythm detection - body temperature. By focusing on this single key parameter rather than continuously monitoring multiple parameters, the system achieves sufficient measurement precision for rhythm detection while significantly reducing device complexity and energy consumption. The temperature data is then used to trigger monitoring of other parameters only when necessary.

Inventive Principle:
Principle #2Taking out (Extraction)

3Reliability

If drug release is synchronized with circadian rhythm peaks, then treatment effectiveness is improved, but device complexity increases due to rhythm detection requirements

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidrhythm detection system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system performs preliminary detection and analysis of circadian rhythms during an initial monitoring period before synchronized drug release is activated. By establishing the patient's rhythm pattern in advance and storing it for later reference, the system can implement rhythm-synchronized drug administration without requiring complex real-time rhythm detection during the actual drug release phase, thereby reducing operational complexity.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS9386925B2Device for drug administration and/or monitoring the status of a patient
Publication Date: 2016.07.12 BT BIDCO INC
  • US9386925B2 patent drawing
  • US9386925B2 patent drawing
  • US9386925B2 patent drawing

AI summary

The invention relates to a device for drug administration and/or monitoring the status of a patient, the device comprising a first and a second measuring means, and the time for using the second measuring means being set in accordance with the data of the first measuring means.